Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 15 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Oruka Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 23 | 32 | +9 |
| Shares | 7.20M | 12.9M | +5.72M (+79.5%) |
| Value | $12.7M | $49.4M | +$36.7M (+289.9%) |
New holders (13)
Institutions that held Oruka Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RTW Investments, LP | 1,400,000 | $5.36M | 0.08% |
| Janus Henderson Group PLC | 1,382,736 | $5.23M | 0.00% |
| Adage Capital Partners GP, L.L.C. | 1,200,000 | $4.60M | 0.01% |
| Avidity Partners Management LP | 1,000,000 | $3.83M | 0.16% |
| VR Adviser, LLC | 866,375 | $3.32M | 0.21% |
| Cowen and Company, LLC | 700,000 | $2.68M | 0.07% |
| Morgan Stanley | 650,000 | $2.49M | 0.00% |
| Commodore Capital LP | 414,325 | $1.59M | 0.11% |
| ADAR1 Capital Management, LLC | 84,676 | $324.3K | 0.07% |
| Affinity Asset Advisors, LLC | 72,484 | $277.6K | 0.04% |
| Cubist Systematic Strategies, LLC | 27,779 | $106.4K | 0.00% |
| Group One Trading, L.P. | 7,131 | $27.3K | 0.00% |
| Activest Wealth Management | 2,000 | $7.66K | 0.00% |
Sold out (4)
Institutions that held Oruka Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Western Standard LLC | 1,410,143 | $2.48M |
| BML Capital Management, LLC | 706,930 | $1.24M |
| HRT Financial LP | 12,714 | $22.0K |
| FMR LLC | 201 | $358 |